Tag: AstraZeneca

AstraZeneca, Daiichi Sankyo get Enhertu FDA approval for HER2-low metastatic breast cancer

businessnewstoday- August 7, 2022 0

Enhertu FDA approval : AstraZeneca and Daiichi Sankyo have secured approval for Enhertu (trastuzumab deruxtecan) from the US Food and Drug Administration for the treatment ... Read More

AstraZeneca to acquire US biotech firm TeneoTwo for up to $1.27bn

businessnewstoday- July 6, 2022 0

UK-based pharma giant AstraZeneca has signed a deal worth up to $1.27 billion to acquire American biotech company TeneoTwo in a move to bolster its ... Read More

AstraZeneca strikes licensing deal with RQ Bio for SARS-CoV-2 targeting mAbs

businessnewstoday- May 18, 2022 0

AstraZeneca has signed a licensing deal with RQ Biotechnology (RQ Bio) to gain access to a portfolio of early-stage monoclonal antibodies (mAbs) targeted against Covid-19 ... Read More

FDA refuses to approve AstraZeneca’s sBLA for Fasenra in CRSwNP

businessnewstoday- March 19, 2022 0

The US Food and Drug Administration (FDA) has refused to approve the supplemental biologics license application (sBLA) of AstraZeneca’s asthma drug Fasenra (benralizumab) for the ... Read More

AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention

businessnewstoday- March 18, 2022 0

AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More

AstraZeneca and Imperial spin-off VaxEquity enter into saRNA partnership

businessnewstoday- September 26, 2021 0

AstraZeneca has signed a collaboration deal with VaxEquity, a spin-off of Imperial College London, for discovering, developing, and commercializing the latter’s self-amplifying RNA (saRNA) therapeutics ... Read More

AstraZeneca to establish $360m API manufacturing facility in Ireland

businessnewstoday- September 25, 2021 0

AstraZeneca said that it will invest $360 million in Ireland for setting up an active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin. ... Read More

AstraZeneca reports positive results for phase 2 COAST trial of oleclumab and monalizumab

businessnewstoday- September 18, 2021 0

AstraZeneca has reported positive results from the COAST phase 2 trial of its oleclumab or monalizumab in combination with Imfinzi (durvalumab) in patients with non-small ... Read More

DESTINY-Gastric02 phase 2 trial results : Enhertu shows clinically meaningful and durable tumor response

businessnewstoday- September 18, 2021 0

AstraZeneca said that Enhertu (trastuzumab deruxtecan) has shown clinically meaningful and durable response in the DESTINY-Gastric02 phase 2 trial featuring patients having HER2-positive advanced gastric ... Read More

AstraZeneca India scraps Dapagliflozin distribution deal with Abbott

businessnewstoday- May 30, 2021 0

AstraZeneca Pharma India (AstraZeneca India) said that it has scrapped its distribution agreement with Abbott Healthcare pertaining to its Type 2 diabetes drug Dapagliflozin in ... Read More